Combining precision medicine and prophylaxis in oesophageal squamous cell carcinoma

A trial update confirms improved survival for prophylactic elective nodal irradiation and addition of erlotinib to definitive chemoradiotherapy in oesophageal squamous cell carcinoma (ESCC). High tumour EGFR protein expression shows promise to identify those who will benefit from erlotinib. This rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Mark A., Spender, Lindsay C., Petty, Russell D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686478/
https://www.ncbi.nlm.nih.gov/pubmed/32958821
http://dx.doi.org/10.1038/s41416-020-01057-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686478/
https://www.ncbi.nlm.nih.gov/pubmed/32958821
http://dx.doi.org/10.1038/s41416-020-01057-3

Ejemplares similares